Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Approach to Surgery Shortens Hospital Stay

By HospiMedica staff writers
Posted on 10 Jul 2001
A study has found that a "fast-track” prostate surgery approach gets men home within 24 hours, compared with up to three days for the standard approach, and with the same high patient satisfaction and low complication rates seen with standard care. More...
The study was presented at the annual meeting of the American Urological Association in Anaheim (CA, USA).

The new approach was developed by researchers at the University of Michigan Medical School (U-M, Ann Arbor, USA). They devised a pathway that uses epidural anesthesia, non-narcotic pain relief, and patient educational materials to help early-stage prostate cancer patients get home sooner, just as safely, and with less expense. They then compared this pathway with standard care in 153 patients who were operated on by U-M surgeons and found that the results were nearly the same.

The new approach coordinates use of a lower-body epidural anesthesia that avoids the "hangover” effect of general anesthesia, non-narcotic pain drugs such as ketorolac and ibuprofen that let patients be more alert and active soon after surgery, and specially developed educational materials that help patients and their families know what to expect regarding postoperative care and at-home care. Just by combining these elements and making a determined effort to offer the patients the option of going home after 24 hours, the U-M team was able to send 77% of patients home after one day's stay, while maintaining a satisfaction rate of 94% and a postoperative complication rate of about 5% In most cases, there was less use of narcotic pain relievers and most were discontinued on the same day as the surgery.

"Since prostatectomy is the most common treatment for early-stage prostate cancer, and indeed is one of the most common cancer operations overall, a more streamlined approach could have a major impact on both patient experience and cost of care,” noted Martin Sanda, M.D., associate professor of urology at U-M and senior author of the study.




Related Links:
University of Michigan

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.